• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

    Acutus Medical Receives FDA Clearance of AcQCross

    Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    PTI Engineered Plastics Inc.

    K-Tube Technologies

    Medbio LLC

    Medicoil
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Medicoil

    Spectrum Plastics Group

    Unicep

    Qosina Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study Links 79 Percent Survival Rate to Impella 5.5 With SmartAssist

    Data show an 86 percent survival rate for cardiomyopathy cardiogenic shock patients.

    Related CONTENT
    • Real-World Medical Device Hacking Tales
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • Acutus Medical Receives FDA Clearance of AcQCross
    Michael Barbella, Managing Editor02.08.21
    Abiomed is touting promising study results for its Impella 5.5 with SmartAssist device. 

    A large clinical study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79 percent survival rate at explant. A majority of surviving patients recovered their native heart function without needing further mechanical support or a heart transplant.

    “This report demonstrates the benefit of the significant unloading with Impella 5.5 use in cardiogenic shock patients. We are impressed with the improved survival rates seen with Impella 5.5 use compared to traditional therapies,” said Scott Silvestry, M.D., co-author of the study and surgical director of thoracic transplant, thoracic and cardiovascular surgery at AdventHealth in Orlando, Fla. “The use of best practices, techniques and this innovative new technology allows us to provide a better outlook to our patients.”

    The study is the first large, multicenter experience examining survival rates with Impella 5.5 with SmartAssist support. It was presented late last month at The Society of Thoracic Surgeons (STS) 2021 Annual Meeting by lead author Edward Soltesz, M.D., MPH, a cardiovascular and heart transplant surgeon at Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute. The data was obtained from the Impella Quality (IQ) database and examined centers with 10 or more patients treated with Impella 5.5 with SmartAssist.
     
    The authors conclude Impella 5.5 with SmartAssist demonstrates successful clinical and device outcomes, including:
    • A 79 percent overall patient survival rate (n=301)
    • An 86 percent survival for cardiomyopathy cardiogenic shock patients (n=141)
    • A 67 percent survival for AMI cardiogenic shock patients (n=88)
    • A 68 percent survival for postcardiotomy cardiogenic shock patients (n=34)

    “We were able to achieve a 79 percent overall survival rate by taking a novel approach in supporting these critically ill patients,” said Dr. Soltesz. “I am looking forward to seeing more prospective studies around this minimally invasive, high-flow temporary device.”
     
    The STS study presentation provides additional evidence of improved outcomes with use of Impella 5.5 with SmartAssist. A study published in July in the American Society for Artificial Internal Organs (ASAIO) Journal found 84 percent survival to explant for Impella 5.5 with SmartAssist patients in cardiogenic shock and other challenging cardiac conditions. Seventy-six percent of those patients achieved native heart recovery. The study examined the outcomes of the first 55 patients treated with Impella 5.5 with SmartAssist at Cleveland Clinic, Hackensack University Medical Center/Hackensack Meridian Health and Cedars-Sinai Medical Center.
     
    In 2019, Impella 5.5 with SmartAssist received the U.S. Food and Drug Administration’s (FDA) highest level of approval for safety and efficacy in the therapy of cardiogenic shock for up to 14 days. Impella 5.5 with SmartAssist delivers peak flows of greater than 6 liters per minute. Benefits of the Impella 5.5 with SmartAssist include:
    • Impella Connect, providing cloud-based remote monitoring
    • Ease of insertion, via the axillary artery or ascending aorta
    • Designed for long-duration support, with patient ambulation, ceramic bearings and no pigtail
    • Forward flow with maximum unloading, to provide end organ and coronary perfusion and allow the heart to rest
    • Enables heart recovery, as a minimally invasive, weanable VAD
    • Ease of patient management, can be intelligently positioned, weaned and managed with SmartAssist
     
    In August, 2020, the FDA granted all left-sided Impella heart pumps, including Impella 5.5 with SmartAssist, an emergency use authorization (EUA) to treat certain patients with COVID-19-related complications who are undergoing extracorporeal membrane oxygenation (ECMO) treatment in the United States.
     
    The Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella LD, and Impella 5.5 with SmartAssist are U.S. FDA-approved to treat heart attack or cardiomyopathy patients in cardiogenic shock, and have the unique ability to enable native heart recovery, allowing patients to return home with their own heart.
     
    Impella Left Ventricular (LV) Support Systems are also authorized for emergency use by HCPs in the hospital setting for providing temporary (≤ four days for Impella 2.5, Impella CP, and Impella CP with SmartAssist; and ≤ 14 days for Impella 5.0 and Impella 5.5 with SmartAssist) LV unloading and support to treat critical care patients with confirmed COVID-19 infection who are undergoing ECMO treatment and who develop pulmonary edema while on V-A ECMO support or late cardiac decompensation from myocarditis while on V-V ECMO support.
     
    Related Searches
    • Cardiovascular
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    How Can a Device End User Aid in Cybersecurity? How Can a Device End User Aid in Cybersecurity?
    What Could Medical Device Hacking’s Future Look Like? What Could Medical Device Hacking’s Future Look Like?
    Real-World Medical Device Hacking Tales Real-World Medical Device Hacking Tales
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Acutus Medical Receives FDA Clearance of AcQCross Acutus Medical Receives FDA Clearance of AcQCross
    Portable Medical Devices Market to Reach $100 Billion by 2027 Portable Medical Devices Market to Reach $100 Billion by 2027
    BD Receives 510(k) Clearance for Pristine Catheter BD Receives 510(k) Clearance for Pristine Catheter
    Vicarious Surgical Appoints CFO and Chief Legal Officer Vicarious Surgical Appoints CFO and Chief Legal Officer
    Nagarro Achieves ISO 13485 Certification Nagarro Achieves ISO 13485 Certification
    MICRO Expands with New Facility in Costa Rica MICRO Expands with New Facility in Costa Rica
    Qosina Announces Expanded Portfolio for Bioprocess Single-use Systems Qosina Announces Expanded Portfolio for Bioprocess Single-use Systems
    Endologix Acquires PQ Bypass Endologix Acquires PQ Bypass
    Elixir Medical Begins Study of Metallic Implant for CAD Treatment Elixir Medical Begins Study of Metallic Implant for CAD Treatment

    Related Breaking News

    • Cardiovascular | Software & IT
      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      The upgrade includes enhanced signal processing for advanced cardiac signal analysis.
      Sam Brusco, Associate Editor 04.14.21

    • Cardiovascular
      Endologix Acquires PQ Bypass

      Endologix Acquires PQ Bypass

      Gains proprietary Detour platform for percutaneous femoral-popliteal bypass.
      Sam Brusco, Associate Editor 04.13.21

    • Cardiovascular
      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Product is designed to adapt to vessel physiology.
      Michael Barbella, Managing Editor 04.13.21


    • Cardiovascular
      USPTO Issues Patent Covering Hancock Jaffe’s VenoValve

      USPTO Issues Patent Covering Hancock Jaffe’s VenoValve

      Valve is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency (CVI).
      Charles Sternberg, Assistant Editor 04.08.21

    • Cardiovascular | Surgical
      Abbott

      Abbott's Next-Gen TriClip Earns EU Nod

      New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve.
      Sam Brusco, Associate Editor 04.08.21

    • Cardiovascular | Patient Monitoring
      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      AI tool continuously calculates the heart’s real-time ejection fraction.
      Sam Brusco, Associate Editor 03.31.21


    • Cardiovascular
      Heart Failure Treatment Using Electrical Microcurrent Shows Promise

      Heart Failure Treatment Using Electrical Microcurrent Shows Promise

      Berlin Heals' C-MIC device restores endogenous electric potential gradients using microcurrents, leading to improved myocardial function.
      Michael Barbella, Managing Editor 03.30.21

    • Cardiovascular
      FDA Breakthrough Status Granted to Cook Medical

      FDA Breakthrough Status Granted to Cook Medical's Zenith Endovascular Graft

      ZFEN+ includes up to five precisely located fenestrations to accommodate the visceral vessels.
      Michael Barbella, Managing Editor 03.29.21

    • Cardiovascular
      FDA Approves Medtronic

      FDA Approves Medtronic's Harmony TPV for Congenital Heart Disease

      Less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract.
      Sam Brusco, Associate Editor 03.26.21


    • Cardiovascular | Surgical
      CSI Buys Peripheral Support Catheters from WavePoint Medical

      CSI Buys Peripheral Support Catheters from WavePoint Medical

      Agreement also includes development of portfolio of chronic total occlusion products.
      Sam Brusco, Associate Editor 03.22.21

    • Cardiovascular
      Cardinal Health to Sell Cordis Biz to Hellman & Friedman for $1B

      Cardinal Health to Sell Cordis Biz to Hellman & Friedman for $1B

      Transaction is expected to close in the first half of Cardinal Health's fiscal year 2022.
      Sam Brusco, Associate Editor 03.12.21

    • Cardiovascular
      Global Cardiovascular Devices Market to Exceed $62 Billion by 2025

      Global Cardiovascular Devices Market to Exceed $62 Billion by 2025

      Sector to be driven in part by the robust performance of cardiac assist products.
      Michael Barbella, Managing Editor 03.12.21


    • Cardiovascular
      China to Lead APAC Interventional Cardiology Devices Market Through 2025

      China to Lead APAC Interventional Cardiology Devices Market Through 2025

      Cardiovascular diseases are the major cause of morbidity and mortality in the nation.
      Michael Barbella, Managing Editor 03.10.21

    • Cardiovascular
      Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

      Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

      Will evaluate PulseSelect's pulsed electrical fields to interrupt irregular heart rhythms.
      Sam Brusco, Associate Editor 03.04.21

    • Cardiovascular
      Soundbite Medical Wins Health Canada Approval for PAD Treatment

      Soundbite Medical Wins Health Canada Approval for PAD Treatment

      Product targets patients with heavily calcified chronic total occlusions.
      Michael Barbella, Managing Editor 03.02.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Thermo Fisher Scientific To Acquire PPD For $17.4 Billion
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • Acutus Medical Receives FDA Clearance of AcQCross
    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    What You're Reading on Happi.com
    Former L’Oréal Exec Joins Glossier
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login